Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillationBRIGNOLE, M; BOTTO, G. L; OSCA ASENSI, J et al.Heart (London 1996). 2012, Vol 98, Num 4, pp 297-302, issn 1355-6037, 6 p.Article

Modulation of ventricular rate in permanent atrial fibrillation : Randomized, crossover study of the effects of slow-release formulations of Gallopamil, diltiazem, or verapamilBOTTO, G. L; BONINI, W; BROFFONI, T et al.Clinical cardiology (Mahwah, NJ). 1998, Vol 21, Num 11, pp 837-840, issn 0160-9289Article

External cardioversion of atrial fibrillation : role of paddle position on technical efficacy and energy requirementsBOTTO, G. L; POLITI, A; BONINI, W et al.Heart (London 1996). 1999, Vol 82, Num 6, pp 726-730, issn 1355-6037Article

Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease : A Randomized, controlled trialBORIANI, G; BIFFI, M; CAPUCCI, A et al.Annals of internal medicine. 1997, Vol 126, Num 8, pp 621-625, issn 0003-4819Article

Conversion of recent-onset atrial fibrillation by a single oral loading dose of Propafenone or flecainideCAPUCCI, A; BORIANI, G; SANGUINETTI, M et al.The American journal of cardiology. 1994, Vol 74, Num 5, pp 503-505, issn 0002-9149Article